Stulak John M, Lim Ju Yong, Maltais Simon
John M. Stulak, Division of Cardiovascular Surgery, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, Minnesota 55905, USA,
Croat Med J. 2014 Dec;55(6):596-9. doi: 10.3325/cmj.2014.55.596.
Advances in mechanical circulatory support have significantly expanded the treatment options for patients with heart failure, whether acute or chronic. There are numerous devices available that offer patients short-, intermediate-, and long-term duration of support depending on their clinical needs and cardiac recovery. Each device has its own technical considerations and the decision which device to use depends on several factors, including what is available, the degree of support required, and expected duration of support. Additional issues that need to be considered in choosing level of support include right heart function, respiratory failure, and multi-organ derangements. A widespread availability of short-term ventricular assist devices and timely institution for effective hemodynamic support will translate into improved patient outcomes whether that is successful transfer to a tertiary care facility or recovery of inherent cardiac function. Implantable ventricular assist devices have and will continue to evolve into smaller and more durable devices, and the future for patients with advanced heart failure looks ever-more promising.
机械循环支持技术的进步显著扩大了心力衰竭患者(无论急性还是慢性)的治疗选择。有许多设备可供使用,可根据患者的临床需求和心脏恢复情况为其提供短期、中期和长期的支持。每种设备都有其自身的技术考量因素,而选择使用哪种设备取决于多个因素,包括可获得的设备、所需的支持程度以及预期的支持持续时间。在选择支持水平时需要考虑的其他问题包括右心功能、呼吸衰竭和多器官功能紊乱。短期心室辅助设备的广泛可用性以及及时建立有效的血流动力学支持,无论患者是成功转至三级医疗机构还是固有心脏功能恢复,都将改善患者的治疗结果。植入式心室辅助设备已经并将继续发展成为更小、更耐用的设备,晚期心力衰竭患者的未来看起来越来越有希望。